Fax: (901) 495-3058
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Supplement
You have full text access to this OnlineOpen article
A model for care across the cancer continuum†
Article first published online: 28 OCT 2005
DOI: 10.1002/cncr.21250
Copyright © 2005 American Cancer Society
Issue
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Cancer
Supplement: Cancer Survivorship: Resilience Across the Lifespan
Volume 104, Issue Supplement 11, pages 2638–2642, 1 December 2005
Additional Information
How to Cite
Hudson, M. M. (2005), A model for care across the cancer continuum. Cancer, 104: 2638–2642. doi: 10.1002/cncr.21250
- †
Presented at Cancer Survivorship: Resilience Across the Lifespan, Washington, DC, June 2–4, 2002.
- ‡
Fax: (901) 495-3058
Publication History
- Issue published online: 18 NOV 2005
- Article first published online: 28 OCT 2005
- Manuscript Accepted: 4 MAY 2005
- Manuscript Received: 28 FEB 2005
REFERENCES
- 1, , , et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55: 10–30.
- 2RiesLAG, EisnerMP, KosaryCL, et al., eds. SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/esr/1975_2002/[Accessed September 12, 2005].
- 3, , , et al. Health status of long-term survivors after cancer in childhood. Results of a multiinstitutional study in Italy. Am J Pediatr Hematol Oncol. 1994; 16: 143–152.
- 4, , , et al. Standardized assessment of late effects in long-term survivors of childhood cancer in Switzerland: results of a Swiss Pediatric Oncology Group (SPOG) pilot study. Int J Pediatr Hematol Oncol. 1996; 3: 483–490.
- 5, , . The health status of adult survivors of cancer in childhood. Eur J Cancer. 1998; 34: 694–698.
- 6, , , et al. Grading of late effects in young adult cancer survivors of childhood cancer following in an ambulatory adult setting. Cancer. 2000; 88: 1687–1695.
- 7, , , et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol. 1997; 15: 2205–2213.
- 8, , , et al. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol. 1998; 16: 3592–3600.
- 9, , , et al. Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol. 1999; 17: 3207–3215.
- 10, , , et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001; 19: 3163–3172.
- 11. Pediatric patients: tolerance levels and effects of treatment. Front Radiat Ther Oncol. 1989; 23: 390–407.
- 12, , , et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992; 166: 788–793.
- 13, , . Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys. 1989; 16: 679–685.
- 14, , . Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993; 11: 1208–1215.
- 15, , , et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991; 324: 808–815.
- 16, , , et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995; 332: 1738–1743.
- 17, . Pulmonary toxicity of antineoplastic therapy. Semin Oncol. 1992; 19: 508–520.
- 18, , , et al. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol. 1989; 17: 477–484.
- 19, , , et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukemia after childhood cancer. Br Med J. 1992; 304: 951–958.
- 20, , , et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol. 1996; 14: 1442–1446.
- 21, , , et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000; 18: 487–497.
- 22, , , et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000; 18: 498–09.
- 23, , , et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol. 2000; 18: 1492–1499.
- 24, , , et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000; 18: 2435–2443.
- 25, , , et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996; 334: 745–751.
- 26, , , et al. Second cancers following pediatric Hodgkin's disease. J Clin Oncol. 1998; 16: 536–544.
- 27, . Treatment of pediatric lymphoma. Semin Hematol. 1999; 36: 313–323.